Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension
- Company
- Imprimis NJOF, LLC
- Where it was sold
-
US Nationwide
Nationwide
- Units affected
- 4,280 boxes
- About this recall
- Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05